XG043

N/A

Report date: 2024/12/02 13:48:27
NME

Base Information

Drug NameXG043
Drug Alias NameXG-043XG043
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-Aminobutyric Acid B Receptor agonistsVoltage-gated calcium channel alpha2/delta subunit 2 modulators
TargetsGamma-Aminobutyric Acid B ReceptorVoltage-gated calcium channel alpha2/delta subunit 2
Therapy Area/IndicationsHeadache
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXgene Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXgene Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHeadache
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A